Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer.

Autor: Wright CL; Wright Center of Innovation in Biomedical Imaging, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH., Washington IR; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL., Bhatt AD; Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH., Knopp MV; Wright Center of Innovation in Biomedical Imaging, Division of Imaging Science, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: knopp.16@osu.edu.
Jazyk: angličtina
Zdroj: Seminars in radiation oncology [Semin Radiat Oncol] 2019 Apr; Vol. 29 (2), pp. 93-101.
DOI: 10.1016/j.semradonc.2018.11.005
Abstrakt: The purpose of this article is to present the recent imaging advancements enabled by digital photon counting positron emission tomography detector technology and discuss its potential applications in the clinical management of head and neck cancer (HNC) and nodal metastases. 18 F-fluorodeoxyglucose positron-emission tomography is a clinically useful biomarker for the detection, targeted biopsy, treatment planning, and therapeutic response assessment of HNC. This article highlights the current state of 18 F-fluorodeoxyglucose positron-emission tomography imaging in HNC management as well as the emerging capabilities of the recently introduced digital photon counting positron emission tomography/computed tomography platform for more effective molecular and functional HNC imaging.
(Copyright © 2018. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: